These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 8718569)
1. Treatment of dyslipidemia in chronic renal failure. Toto RD Blood Purif; 1996; 14(1):75-82. PubMed ID: 8718569 [TBL] [Abstract][Full Text] [Related]
2. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy. Oki JC Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166 [TBL] [Abstract][Full Text] [Related]
3. Treatment of dyslipidemia in chronic kidney disease. Stefanovic V; Milojkovic M Int J Artif Organs; 2004 Oct; 27(10):821-7. PubMed ID: 15560675 [TBL] [Abstract][Full Text] [Related]
4. Effects of lipid-lowering therapy on reduction of cardiovascular events in patients with end-stage renal disease requiring hemodialysis. Marrs JC; Saseen JJ Pharmacotherapy; 2010 Aug; 30(8):823-9. PubMed ID: 20653359 [TBL] [Abstract][Full Text] [Related]
5. [Treatment of hyperlipidemia]. Yoshino G Rinsho Byori; 2002 Mar; 50(3):254-61. PubMed ID: 11985052 [TBL] [Abstract][Full Text] [Related]
6. Lipid abnormalities in chronic renal failure, nephrotic syndrome and dialysis. Kes P Acta Med Croatica; 2001; 55(4-5):177-86. PubMed ID: 12398021 [TBL] [Abstract][Full Text] [Related]
7. [Lipoprotein disorders in chronic kidney failure, nephrotic syndrome and dialysis]. Kes P; Reiner Z; Brunetta B Lijec Vjesn; 2002; 124(11-12):372-7. PubMed ID: 12679979 [TBL] [Abstract][Full Text] [Related]
9. Management of dyslipidemia in primary care. Alzahrani T; Marrat S; Haider A Can J Cardiol; 2003 Dec; 19(13):1499-502. PubMed ID: 14760440 [TBL] [Abstract][Full Text] [Related]
10. Hyperlipidemia in children with type 2 diabetes mellitus. Taha D J Pediatr Endocrinol Metab; 2002 Apr; 15 Suppl 1():505-7. PubMed ID: 12017224 [TBL] [Abstract][Full Text] [Related]
11. Treatment of hyperlipidemia in human renal disease. D'Amico GD; Gentile MG Miner Electrolyte Metab; 1993; 19(3):196-204. PubMed ID: 8232107 [TBL] [Abstract][Full Text] [Related]
12. Dyslipidemia in pediatric renal disease: epidemiology, pathophysiology, and management. Saland JM; Ginsberg H; Fisher EA Curr Opin Pediatr; 2002 Apr; 14(2):197-204. PubMed ID: 11981290 [TBL] [Abstract][Full Text] [Related]
13. Control of lipid disorders in patients with atherosclerotic vascular disease. Marks AD Surg Clin North Am; 1998 Jun; 78(3):431-46. PubMed ID: 9673655 [TBL] [Abstract][Full Text] [Related]
14. When and how to treat hyperlipidemia. Kuo PT Prim Care; 1985 Mar; 12(1):77-89. PubMed ID: 3873080 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms and treatment of dyslipidemia of renal diseases. Toto RD; Vega GL; Grundy SM Curr Opin Nephrol Hypertens; 1993 Sep; 2(5):784-90. PubMed ID: 7922219 [TBL] [Abstract][Full Text] [Related]
16. Severe hypertriglyceridemia in an infant on chronic hemodialysis. Aly R; Acharya R; Upadhyay KK Hemodial Int; 2023 Jan; 27(1):E1-E4. PubMed ID: 36259088 [TBL] [Abstract][Full Text] [Related]
17. Management of dyslipidemia in the high-risk patient. Stein EA Am Heart J; 2002 Dec; 144(6 Suppl):S43-50. PubMed ID: 12486415 [TBL] [Abstract][Full Text] [Related]
18. Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study. Akçiçek F; Ok E; Duman S; Kürsad S; Unsal A; Alev M; Atabay G; Basçi A Adv Perit Dial; 1996; 12():261-5. PubMed ID: 8865916 [TBL] [Abstract][Full Text] [Related]
19. [Hypertension, dyslipidemia and cardiovascular risk in chronic renal disease]. Ravera M; Paoletti E Ital Heart J Suppl; 2004 Jun; 5(6):436-44. PubMed ID: 15471148 [TBL] [Abstract][Full Text] [Related]